Legal & General Group’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$421K Buy
72,910
+18,930
+35% +$109K ﹤0.01% 2488
2025
Q1
$356K Hold
53,980
﹤0.01% 2506
2024
Q4
$470K Sell
53,980
-110
-0.2% -$958 ﹤0.01% 2477
2024
Q3
$1.06M Sell
54,090
-1,610
-3% -$31.5K ﹤0.01% 2215
2024
Q2
$1.15M Buy
55,700
+2,783
+5% +$57.3K ﹤0.01% 2146
2024
Q1
$1.13M Sell
52,917
-668
-1% -$14.2K ﹤0.01% 2153
2023
Q4
$771K Hold
53,585
﹤0.01% 2292
2023
Q3
$489K Sell
53,585
-124
-0.2% -$1.13K ﹤0.01% 2452
2023
Q2
$568K Buy
53,709
+19,538
+57% +$207K ﹤0.01% 2423
2023
Q1
$418K Buy
34,171
+11,798
+53% +$144K ﹤0.01% 2370
2022
Q4
$278K Buy
22,373
+857
+4% +$10.6K ﹤0.01% 2490
2022
Q3
$294K Buy
21,516
+1,049
+5% +$14.3K ﹤0.01% 2482
2022
Q2
$376K Buy
20,467
+1,225
+6% +$22.5K ﹤0.01% 2413
2022
Q1
$309K Hold
19,242
﹤0.01% 2531
2021
Q4
$270K Hold
19,242
﹤0.01% 2598
2021
Q3
$360K Buy
19,242
+11,123
+137% +$208K ﹤0.01% 2516
2021
Q2
$169K Sell
8,119
-1,742
-18% -$36.3K ﹤0.01% 2587
2021
Q1
$278K Buy
9,861
+451
+5% +$12.7K ﹤0.01% 2393
2020
Q4
$307K Buy
9,410
+907
+11% +$29.6K ﹤0.01% 2342
2020
Q3
$261K Sell
8,503
-2,310
-21% -$70.9K ﹤0.01% 2314
2020
Q2
$176K Buy
10,813
+4,107
+61% +$66.8K ﹤0.01% 2382
2020
Q1
$64K Sell
6,706
-1,151
-15% -$11K ﹤0.01% 2525
2019
Q4
$108K Buy
7,857
+1,271
+19% +$17.5K ﹤0.01% 2572
2019
Q3
$100K Buy
6,586
+685
+12% +$10.4K ﹤0.01% 2517
2019
Q2
$116K Buy
5,901
+409
+7% +$8.04K ﹤0.01% 2481
2019
Q1
$91K Buy
5,492
+317
+6% +$5.25K ﹤0.01% 2523
2018
Q4
$73K Buy
5,175
+923
+22% +$13K ﹤0.01% 2554
2018
Q3
$74K Buy
4,252
+519
+14% +$9.03K ﹤0.01% 2592
2018
Q2
$68K Sell
3,733
-78
-2% -$1.42K ﹤0.01% 2618
2018
Q1
$71K Sell
3,811
-1,244
-25% -$23.2K ﹤0.01% 2603
2017
Q4
$79K Buy
5,055
+1,750
+53% +$27.3K ﹤0.01% 2692
2017
Q3
$49K Buy
3,305
+1,195
+57% +$17.7K ﹤0.01% 2913
2017
Q2
$20K Buy
+2,110
New +$20K ﹤0.01% 3190